Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 12NIH 4NETWORK 3INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Plasma cell 1

Conditions

Lymphoma 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Leukemia 14Lymphoma, Large B-Cell, Diffuse 13Prostatic Neoplasms 11Lymphoma, Follicular 11Hodgkin Disease 11Burkitt Lymphoma 11Multiple Myeloma 7Lymphoma, Large-Cell, Anaplastic 5Leukemia, Biphenotypic, Acute 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms, Plasma Cell 4Dendritic Cell Sarcoma, Interdigitating 4Waldenstrom Macroglobulinemia 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell, Marginal Zone 2Immunoblastic Lymphadenopathy 2Cardiotoxicity 2Thymoma 1Thrombocytopenia 1Sezary Syndrome 1Recurrence 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmablastic Lymphoma 1Pain 1Neutropenia 1

Interventions

Cyclophosphamide 11Rituximab 9fludarabine phosphate 7fludarabine 4Whole-Body Irradiation 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Methotrexate 4Alemtuzumab 4Tacrolimus 3Prednisone 3Melphalan 3Cytogenetic Analysis 3Busulfan 3Vincristine 2Pentostatin 2Patient Reported Outcome Measures 2Mesna 2In Situ Hybridization, Fluorescence 2Gene Expression Profiling 2Flow Cytometry 2Filgrastim 2Doxorubicin 2Bendamustine Hydrochloride 2ruxolitinib 1plerixafor 1pegfilgrastim 1merphos 1liposomal amphotericin B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Lymphocytic, Chronic, B-Cell × Prednisone × Clear all
NCT00003910 2023-07-05

Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia

Eastern Cooperative Oncology Group

Phase 2 Terminated
59 enrolled 8 charts
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Large Granular Lymphocytic

NCT00801281 2017-07-17

PLRG4

Polish Lymphoma Research Group

Phase 3 Completed
250 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT00002657 2013-01-24

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

SWOG Cancer Research Network

Phase 2 Completed
20 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡